Moran Wealth Management
ABBV icon

Moran Wealth Management’s AbbVie ABBV Stock Holding History

Moran Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$705K Buy
2,695
+832
+45% +$213K 0.02% 394
2026
Q2 		$469K Buy
+1,863
New +$401K 0.01% 425
2023
Q3 		– Sell
-3,718
Closed -$501K – 368
2023
Q2 		$501K Sell
3,718
-1,199
-24% -$176K 0.02% 304
2023
Q1 		$784K Sell
4,917
-128,986
-96% -$19.7M 0.03% 272
2022
Q4 		$21.6M Buy
+133,903
New +$20.5M 0.82% 28

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Moran Wealth Management's ABBV Position: Q3 2026 in Review

Moran Wealth Management increased its AbbVie (ABBV) stake by 45% in Q3 2026, buying an estimated $213K and bringing the position to 2,695 shares worth $705K. The position accounts for 0.02% of the portfolio, ranked #394.

Moran Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 5 quarters since. The position peaked at $21.6M in Q4 2022. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Moran Wealth Management held 2,695 shares of AbbVie worth $705K as of Q3 2026.
  • Moran Wealth Management bought 832 AbbVie shares in Q3 2026, an estimated $213K.
  • AbbVie made up 0.02% of Moran Wealth Management's portfolio in Q3 2026, its #394 holding.
  • Moran Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 5 quarters since.
  • Moran Wealth Management's AbbVie position peaked at $21.6M in Q4 2022.
  • 1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Moran Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.